4.6 Article

Targeting AMPK in the treatment of malignancies

Journal

JOURNAL OF CELLULAR BIOCHEMISTRY
Volume 113, Issue 2, Pages 404-409

Publisher

WILEY
DOI: 10.1002/jcb.23369

Keywords

AMPK; mTOR; CANCER

Ask authors/readers for more resources

The AMPK pathway is a metabolic stress-related and energy censor pathway which plays important regulatory roles in normal and malignant cells. This cellular cascade controls generation of signals for initiation of mRNA translation via the mTOR pathway and exhibits regulatory roles on the initiation of autophagy. AMPK activators have been shown to suppress mTOR activity and to negatively control malignant transformation and cell proliferation of diverse malignant cell types. Such properties of AMPK inducers have generated substantial interest for the use of AMPK targeting compounds as antineoplastic agents and have provoked extensive research efforts to better define and classify the mechanisms controlling AMPK activity and its functional consequences in malignant cells. J. Cell. Biochem. 113: 404409, 2012. (C) 2011 Wiley Periodicals, Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available